agilon health, inc. - Common stock, $0.01 par value (AGL)

CUSIP: 00857U107

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
-18,864,086
Put/Call ratio
147%
SEC-reported price per share
$4.33
Indexed holders
198
Value change
-$76,575,360
Number of buys
108
Open additional details 1 more signal available
Number of sells
70
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,608,126

Security key

00857U107

Report period

Q1 2025

Indexed institutions

198

Top holders

10

Ownership snapshot

Top reported holders of AGL - agilon health, inc. - Common stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
CD&R Investment Associate...
Comparable rows
2/15
Latest evidence
31 Mar 2025
13D/G 13F 3/4/5 Lead comparable stake: 12% 13 rows are not safely comparable across share classes. 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 12%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 2
MORGAN STANLEY 12%
WELLINGTON MANAGEMENT GROUP LLP 3.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13D/G 13F
Company
12%
Reported 13D/G · 31 Mar 2025
$192,768,956
50,200,249 shares
$0 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
3.6%
Reported 13D/G · 31 Mar 2025
$99,901,027
52,579,488 shares
— 31 Dec 2024
CD&R Investment Associates IX, Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$1,122,000,000
100,000,000 shares
— 18 May 2023
Clayton, Dubilier & Rice, LLC
13F
Company
13F
—
denominator unverified
$190,000,000
100,000,000 shares
— 31 Dec 2024
Capital World Investors
13F
Company
13F
—
denominator unverified
$87,985,648
46,308,236 shares
— 31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$59,113,574
31,112,407 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
198
Shares
399,826,350
Indexed holders
198
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 indexed holders
183
Q1 2025 indexed holders
198
Indexed holder difference
15
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .